Cost of Entyvio: Saving Strategies and Additional Information
News Article: Understanding the Cost of Entyvio for Patients
The cost of Entyvio, a popular biologic drug used to treat various inflammatory bowel diseases, can vary significantly for patients. Here's a breakdown of the factors that influence the cost.
Insurance Coverage
The extent of a patient's health insurance can significantly impact the out-of-pocket expenses. Medicare, for instance, may cover portions of the cost, such as Part D for infusion prices and Part B for doctor's office visits. However, the specific coverage depends on individual plan coverage and benefits.
Treatment Plan
The dosing schedule for Entyvio affects the total cost. Initially, two injections are given in the first month, followed by either every 8 weeks for infusions or every 2 weeks for subcutaneous injections.
Pharmacy or Healthcare Provider
Prices can also vary depending on where the medication is purchased or administered. Entyvio may need to be purchased through a specialty pharmacy authorized to carry specialty drugs, and infusions are typically administered by healthcare professionals in their office or infusion clinic.
Availability of Savings Programs or Coupons
Manufacturer coupons and drug savings programs can lower patient costs substantially. One such program is the EntyvioConnect copay card, available for those with private health insurance.
Brand-Name Status
As a brand-name biologic drug, Entyvio does not have a biosimilar version, which can result in generally higher costs due to research and patent protections.
Financial Assistance Programs
Financial aid options include manufacturer savings programs and coupons that patients can use to reduce out-of-pocket expenses. Assistance programs often consider insurance status and treatment plan to help lower costs. It's recommended that patients speak with their doctor, pharmacist, or insurance provider to learn what specific assistance and savings programs are available to them locally.
International Costs
Costs vary internationally. For example, in Sweden, the annual cost of vedolizumab treatment has been reported above €10,000 per treatment year, driven mainly by medication expenses.
For a detailed comparison of Entyvio's forms and their cost, patients are advised to consult with a doctor, pharmacist, or insurance provider. Additionally, websites such as Medicine Assistance Tool and NeedyMeds provide details about drug assistance programs and savings cards. It's important for patients to remember that the cost of Entyvio can vary based on factors such as treatment plan, insurance coverage, and the cost of doctor visits. For a precise estimate, patients should call their plan provider for details.
- For patients with ulcerative colitis or Crohn's disease, the cost of Entyvio, a biologic drug used to treat various inflammatory bowel diseases, can be impacted by factors such as insurance coverage, treatment plan, pharmacy or healthcare provider, availability of savings programs, brand-name status, and financial assistance programs.
- Medicare may cover portions of Entyvio's cost, but the specific coverage depends on individual plan coverage and benefits.
- The AbbVie-sponsored EntyvioConnect copay card can help reduce out-of-pocket expenses for those with private health insurance.
- Science and research have not yet produced a biosimilar version of Entyvio, resulting in generally higher costs due to patent protections.
- In Sweden, the annual cost of vedolizumab, a similar drug to Entyvio, has been reported above €10,000 per treatment year, driven mainly by medication expenses.
- To obtain a detailed comparison of Entyvio's forms and their cost, patients should consult with their doctor, pharmacist, or insurance provider, and can also seek additional information from websites such as Medicine Assistance Tool and NeedyMeds.
